The exact text we saved

This is the version exactly as it was saved, character for character. The SHA-256 hash below is a 64-character code worked out from that text. Run the same text through SHA-256 and you get the same code; change a single letter and the code comes out completely different. Each version also stores the previous version’s hash, which chains them together so no version can be swapped out quietly.

TRUVACE RECORD VERSION
record: TRV-2026-1168
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-09-22T06:53:42.913940Z
status: published
lens: p_space
sector: health
headline: From Answers to Agents: What Must Change Before Generative and Agentic AI Become Clinical Infrastructure in Hematology
dek: Generative artificial intelligence in hematology is entering a new phase. The dominant question, whether large language models are accurate enough for clinical decision support, is being overtaken by a harder one, as systems shift from answering questions to acting: extracting structured cases, routing them, classifying variants, and grounding recommendations in guidelines and case memory. In 2026, a hematology agent achieved roughly 83% concordance with tumor-board decisions in a prospective silent trial, with…
gain_title: (none)
problem_title: From Answers to Agents: What Must Change Before Generative and Agentic AI Become Clinical Infrastructure in Hematology: In 2026, a hematology agent achieved roughly 83% concordance with tumor-board decisions in a prospective silent trial, with hallucinations in 0.3%, suggesting that for well-structured tasks the binding constraint is shifting from accuracy to governability.
trace_subject: (none)
gain_reading: (none)
gain_evidence: (none)
problem_reading: From Answers to Agents: What Must Change Before Generative and Agentic AI Become Clinical Infrastructure in Hematology: In 2026, a hematology agent achieved roughly 83% concordance with tumor-board decisions in a prospective silent trial, with hallucinations in 0.3%, suggesting that for well-structured tasks the binding constraint is shifting from accuracy to governability.
problem_evidence: (none)
quick_read: Generative artificial intelligence in hematology is entering a new phase. The dominant question, whether large language models are accurate enough for clinical decision support, is being overtaken by a harder one, as systems shift from answering questions to acting: extracting structured cases, routing them, classifying variants, and grounding recommendations in guidelines and case memory.

In 2026, a hematology agent achieved roughly 83% concordance with tumor-board decisions in a prospective silent trial, with hallucinations in 0.3%, suggesting that for well-structured tasks the binding constraint is shifting from accuracy to governability. For hematologists, this reframes AI adoption as a governance and human-factors program rather than a search for a better model.
limitation: 
tag: Evidence-backed problem
key_points: Generative artificial intelligence in hematology is entering a new phase. | The dominant question, whether large language models are accurate enough for clinical decision support, is being overtaken by a harder one, as systems shift from answering questions to acting: extracting structured cases, routing them, classifying variants, and grounding recommendations in guidelines and case memory. | In 2026, a hematology agent achieved roughly 83% concordance with tumor-board decisions in a prospective silent trial, with hallucinations in 0.3%, suggesting that for well-structured tasks the binding constraint is shifting from accuracy to governability.
rundown: Generative artificial intelligence in hematology is entering a new phase. The dominant question, whether large language models are accurate enough for clinical decision support, is being overtaken by a harder one, as systems shift from answering questions to acting: extracting structured cases, routing them, classifying variants, and grounding recommendations in guidelines and case memory.

In 2026, a hematology agent achieved roughly 83% concordance with tumor-board decisions in a prospective silent trial, with hallucinations in 0.3%, suggesting that for well-structured tasks the binding constraint is shifting from accuracy to governability. Moving from experimental support to reliable infrastructure requires four changes: validating trajectories rather than answers; allocating autonomy inversely to case complexity; treating deployed models as regulated instruments under continuous surveillance; and engineering against automation bias, with data-privacy and consent safeguards throughout.
sources:
- peer_reviewed | Turkish Journal of Hematology | https://doi.org/10.4274/tjh.galenos.2026.82621 | 2026-09-21
prev: 0000000000000000000000000000000000000000000000000000000000000000

SHA-256 hash

588383241407bfcb3bd959823d26fd7aff5391ae6b3cb1eb27e6208b6ea4fda8

Previous version’s hash

0000000000000000000000000000000000000000000000000000000000000000